Autoimmune Diseases  >>  sirolimus  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sirolimus / Generic mfg.
NCT01914770: Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

Completed
N/A
1016
US
Belimumab 1 mg/kg, Belimumab 10 mg/kg, Placebo
GlaxoSmithKline, Human Genome Sciences Inc.
Systemic Lupus Erythematosus
11/10
11/10
NCT01672151: Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

Completed
N/A
35
RoW
rapamycin, sirolimus
First Affiliated Hospital of Suzhou Medical College
Immune Thrombocytopenic Purpura
08/12
08/12
NCT01033500: Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

Withdrawn
N/A
0
US
Belatacept
University of Wisconsin, Madison, Bristol-Myers Squibb
Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney Transplantation
12/12
12/12
NCT01049633: B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

No Longer Available
N/A
US
Allogeneic Pancreatic Islet Cells, Sirolimus, Basiliximab, Tacrolimus, Antibacterial, Antifungal, and Antiviral Prophylaxis, Trimethoprim/sulfamethoxazole, Septra SS, Clotrimazole, Mycelex Troche, Valganciclovir, Valcyte, Heparin, Anticoagulation and Hematological Agent, Enoxaparin, Lovenox; Anticoagulation and Hematological Agent, Pentoxifylline, Aspirin, ASA
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type 1 Diabetes Mellitus
 
 
NCT01309022: Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

No Longer Available
N/A
US
Sirolimus, Rapamune®, Tacrolimus, Prograf®, Mycophenolate mofetil, MMF, CellCept, Mycophenolic acid, Myfortic®
National Institute of Allergy and Infectious Diseases (NIAID), Immune Tolerance Network (ITN)
Diabetes Mellitus, Type 1
 
 
NCT01369082: Extended Follow-Up After Islet Transplantation in T1D

Completed
N/A
75
US
Maintenance Immunosuppressive Treatment, tacrolimus, Prograf®, FK506, sirolimus, rapamycin, Rapamune®, cyclosporine, Neoral®, mycophenolate mofetil (MMF), CellCept®, mycophenolic sodium, Myfortic®
National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Clinical Islet Transplantation Consortium
Type 1 Diabetes (T1D), Islet Transplantation
07/17
07/17

Download Options